The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Digital PCR and Real-time PCR(qPCR) Market Research Report 2024
Synopsis
Real-time PCR or quantitative PCR is a well-established technology that has become the tool of choice for the rapid, sensitive quantification of nucleic acid in various biological samples. qPCR measures the accumulation of DNA during a PCR reaction. The increase in quantity of DNA at each cycle is measured by the change in intensity of a fluorescent signal. Comparison to a reference sample determines the number of original copies of template DNA in the reaction.Digital PCR is a highly precise approach to sensitive nucleic acid detection and quantification. Each sample is partitioned into thousands of individual reactions (droplets for Droplet Digital™ PCR technology). Each partition is analyzed after end-point PCR cycling for the presence or absence of a fluorescent signal, and the absolute number of molecules present in the sample is calculated. dPCR does not require a standard curve for quantification.Both quantitative PCR (qPCR) and digital PCR (dPCR) provide sensitive and specific detection, and precise quantification of nucleic acids. Both technologies have similarities, but they have differences that make one or the other the more adapted choice for specific applications.
The global Digital PCR and Real-time PCR(qPCR) market was valued at US$ 1315 million in 2023 and is anticipated to reach US$ 1901.9 million by 2030, witnessing a CAGR of 5.3% during the forecast period 2024-2030.
Global Digital PCR (DPCR) and QPCR key players include Thermo Fisher, Roche, QIAGEN, Bio-rad, Agilent, etc. Global top five manufacturers hold a share about 75%.
North America is the largest market, with a share about 50%, followed by Europe and China, both have a share about 40 percent.
In terms of product, qPCR is the largest segment, with a share about 70%. And in terms of application, the largest application is Research Use, followed by Clinical Use.
This report aims to provide a comprehensive presentation of the global market for Digital PCR and Real-time PCR(qPCR), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Digital PCR and Real-time PCR(qPCR).
Report Scope
The Digital PCR and Real-time PCR(qPCR) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Digital PCR and Real-time PCR(qPCR) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Digital PCR and Real-time PCR(qPCR) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Thermo Fisher Scientific
Bio-Rad Laboratories
Qiagen
Takara Bio
Agilent Technologies
Biomerieux
Fluidigm Corporation
Danaher
ABBott Laboratories
Merck KGaA
Becton Dickinson
Promega Corporation
Meridian Bioscience
Analytik Jena AG
Segment by Type
Instrument
Reagent
Segment by Application
Oncology
Blood Testing
Pathogen Detection
Research
Forensic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Digital PCR and Real-time PCR(qPCR) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Real-time PCR or quantitative PCR is a well-established technology that has become the tool of choice for the rapid, sensitive quantification of nucleic acid in various biological samples. qPCR measures the accumulation of DNA during a PCR reaction. The increase in quantity of DNA at each cycle is measured by the change in intensity of a fluorescent signal. Comparison to a reference sample determines the number of original copies of template DNA in the reaction.Digital PCR is a highly precise approach to sensitive nucleic acid detection and quantification. Each sample is partitioned into thousands of individual reactions (droplets for Droplet Digital™ PCR technology). Each partition is analyzed after end-point PCR cycling for the presence or absence of a fluorescent signal, and the absolute number of molecules present in the sample is calculated. dPCR does not require a standard curve for quantification.Both quantitative PCR (qPCR) and digital PCR (dPCR) provide sensitive and specific detection, and precise quantification of nucleic acids. Both technologies have similarities, but they have differences that make one or the other the more adapted choice for specific applications.
The global Digital PCR and Real-time PCR(qPCR) market was valued at US$ 1315 million in 2023 and is anticipated to reach US$ 1901.9 million by 2030, witnessing a CAGR of 5.3% during the forecast period 2024-2030.
Global Digital PCR (DPCR) and QPCR key players include Thermo Fisher, Roche, QIAGEN, Bio-rad, Agilent, etc. Global top five manufacturers hold a share about 75%.
North America is the largest market, with a share about 50%, followed by Europe and China, both have a share about 40 percent.
In terms of product, qPCR is the largest segment, with a share about 70%. And in terms of application, the largest application is Research Use, followed by Clinical Use.
This report aims to provide a comprehensive presentation of the global market for Digital PCR and Real-time PCR(qPCR), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Digital PCR and Real-time PCR(qPCR).
Report Scope
The Digital PCR and Real-time PCR(qPCR) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Digital PCR and Real-time PCR(qPCR) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Digital PCR and Real-time PCR(qPCR) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Thermo Fisher Scientific
Bio-Rad Laboratories
Qiagen
Takara Bio
Agilent Technologies
Biomerieux
Fluidigm Corporation
Danaher
ABBott Laboratories
Merck KGaA
Becton Dickinson
Promega Corporation
Meridian Bioscience
Analytik Jena AG
Segment by Type
Instrument
Reagent
Segment by Application
Oncology
Blood Testing
Pathogen Detection
Research
Forensic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Digital PCR and Real-time PCR(qPCR) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Digital PCR and Real-time PCR(qPCR) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Instrument
1.2.3 Reagent
1.3 Market by Application
1.3.1 Global Digital PCR and Real-time PCR(qPCR) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Blood Testing
1.3.4 Pathogen Detection
1.3.5 Research
1.3.6 Forensic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Digital PCR and Real-time PCR(qPCR) Market Perspective (2019-2030)
2.2 Digital PCR and Real-time PCR(qPCR) Growth Trends by Region
2.2.1 Global Digital PCR and Real-time PCR(qPCR) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Digital PCR and Real-time PCR(qPCR) Historic Market Size by Region (2019-2024)
2.2.3 Digital PCR and Real-time PCR(qPCR) Forecasted Market Size by Region (2025-2030)
2.3 Digital PCR and Real-time PCR(qPCR) Market Dynamics
2.3.1 Digital PCR and Real-time PCR(qPCR) Industry Trends
2.3.2 Digital PCR and Real-time PCR(qPCR) Market Drivers
2.3.3 Digital PCR and Real-time PCR(qPCR) Market Challenges
2.3.4 Digital PCR and Real-time PCR(qPCR) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Digital PCR and Real-time PCR(qPCR) Players by Revenue
3.1.1 Global Top Digital PCR and Real-time PCR(qPCR) Players by Revenue (2019-2024)
3.1.2 Global Digital PCR and Real-time PCR(qPCR) Revenue Market Share by Players (2019-2024)
3.2 Global Digital PCR and Real-time PCR(qPCR) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Digital PCR and Real-time PCR(qPCR) Revenue
3.4 Global Digital PCR and Real-time PCR(qPCR) Market Concentration Ratio
3.4.1 Global Digital PCR and Real-time PCR(qPCR) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Digital PCR and Real-time PCR(qPCR) Revenue in 2023
3.5 Digital PCR and Real-time PCR(qPCR) Key Players Head office and Area Served
3.6 Key Players Digital PCR and Real-time PCR(qPCR) Product Solution and Service
3.7 Date of Enter into Digital PCR and Real-time PCR(qPCR) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Digital PCR and Real-time PCR(qPCR) Breakdown Data by Type
4.1 Global Digital PCR and Real-time PCR(qPCR) Historic Market Size by Type (2019-2024)
4.2 Global Digital PCR and Real-time PCR(qPCR) Forecasted Market Size by Type (2025-2030)
5 Digital PCR and Real-time PCR(qPCR) Breakdown Data by Application
5.1 Global Digital PCR and Real-time PCR(qPCR) Historic Market Size by Application (2019-2024)
5.2 Global Digital PCR and Real-time PCR(qPCR) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Digital PCR and Real-time PCR(qPCR) Market Size (2019-2030)
6.2 North America Digital PCR and Real-time PCR(qPCR) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Digital PCR and Real-time PCR(qPCR) Market Size by Country (2019-2024)
6.4 North America Digital PCR and Real-time PCR(qPCR) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Digital PCR and Real-time PCR(qPCR) Market Size (2019-2030)
7.2 Europe Digital PCR and Real-time PCR(qPCR) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Digital PCR and Real-time PCR(qPCR) Market Size by Country (2019-2024)
7.4 Europe Digital PCR and Real-time PCR(qPCR) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Digital PCR and Real-time PCR(qPCR) Market Size (2019-2030)
8.2 Asia-Pacific Digital PCR and Real-time PCR(qPCR) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Digital PCR and Real-time PCR(qPCR) Market Size by Region (2019-2024)
8.4 Asia-Pacific Digital PCR and Real-time PCR(qPCR) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Digital PCR and Real-time PCR(qPCR) Market Size (2019-2030)
9.2 Latin America Digital PCR and Real-time PCR(qPCR) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Digital PCR and Real-time PCR(qPCR) Market Size by Country (2019-2024)
9.4 Latin America Digital PCR and Real-time PCR(qPCR) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Digital PCR and Real-time PCR(qPCR) Market Size (2019-2030)
10.2 Middle East & Africa Digital PCR and Real-time PCR(qPCR) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Digital PCR and Real-time PCR(qPCR) Market Size by Country (2019-2024)
10.4 Middle East & Africa Digital PCR and Real-time PCR(qPCR) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Digital PCR and Real-time PCR(qPCR) Introduction
11.1.4 Roche Revenue in Digital PCR and Real-time PCR(qPCR) Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Digital PCR and Real-time PCR(qPCR) Introduction
11.2.4 Thermo Fisher Scientific Revenue in Digital PCR and Real-time PCR(qPCR) Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Detail
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Digital PCR and Real-time PCR(qPCR) Introduction
11.3.4 Bio-Rad Laboratories Revenue in Digital PCR and Real-time PCR(qPCR) Business (2019-2024)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Qiagen
11.4.1 Qiagen Company Detail
11.4.2 Qiagen Business Overview
11.4.3 Qiagen Digital PCR and Real-time PCR(qPCR) Introduction
11.4.4 Qiagen Revenue in Digital PCR and Real-time PCR(qPCR) Business (2019-2024)
11.4.5 Qiagen Recent Development
11.5 Takara Bio
11.5.1 Takara Bio Company Detail
11.5.2 Takara Bio Business Overview
11.5.3 Takara Bio Digital PCR and Real-time PCR(qPCR) Introduction
11.5.4 Takara Bio Revenue in Digital PCR and Real-time PCR(qPCR) Business (2019-2024)
11.5.5 Takara Bio Recent Development
11.6 Agilent Technologies
11.6.1 Agilent Technologies Company Detail
11.6.2 Agilent Technologies Business Overview
11.6.3 Agilent Technologies Digital PCR and Real-time PCR(qPCR) Introduction
11.6.4 Agilent Technologies Revenue in Digital PCR and Real-time PCR(qPCR) Business (2019-2024)
11.6.5 Agilent Technologies Recent Development
11.7 Biomerieux
11.7.1 Biomerieux Company Detail
11.7.2 Biomerieux Business Overview
11.7.3 Biomerieux Digital PCR and Real-time PCR(qPCR) Introduction
11.7.4 Biomerieux Revenue in Digital PCR and Real-time PCR(qPCR) Business (2019-2024)
11.7.5 Biomerieux Recent Development
11.8 Fluidigm Corporation
11.8.1 Fluidigm Corporation Company Detail
11.8.2 Fluidigm Corporation Business Overview
11.8.3 Fluidigm Corporation Digital PCR and Real-time PCR(qPCR) Introduction
11.8.4 Fluidigm Corporation Revenue in Digital PCR and Real-time PCR(qPCR) Business (2019-2024)
11.8.5 Fluidigm Corporation Recent Development
11.9 Danaher
11.9.1 Danaher Company Detail
11.9.2 Danaher Business Overview
11.9.3 Danaher Digital PCR and Real-time PCR(qPCR) Introduction
11.9.4 Danaher Revenue in Digital PCR and Real-time PCR(qPCR) Business (2019-2024)
11.9.5 Danaher Recent Development
11.10 ABBott Laboratories
11.10.1 ABBott Laboratories Company Detail
11.10.2 ABBott Laboratories Business Overview
11.10.3 ABBott Laboratories Digital PCR and Real-time PCR(qPCR) Introduction
11.10.4 ABBott Laboratories Revenue in Digital PCR and Real-time PCR(qPCR) Business (2019-2024)
11.10.5 ABBott Laboratories Recent Development
11.11 Merck KGaA
11.11.1 Merck KGaA Company Detail
11.11.2 Merck KGaA Business Overview
11.11.3 Merck KGaA Digital PCR and Real-time PCR(qPCR) Introduction
11.11.4 Merck KGaA Revenue in Digital PCR and Real-time PCR(qPCR) Business (2019-2024)
11.11.5 Merck KGaA Recent Development
11.12 Becton Dickinson
11.12.1 Becton Dickinson Company Detail
11.12.2 Becton Dickinson Business Overview
11.12.3 Becton Dickinson Digital PCR and Real-time PCR(qPCR) Introduction
11.12.4 Becton Dickinson Revenue in Digital PCR and Real-time PCR(qPCR) Business (2019-2024)
11.12.5 Becton Dickinson Recent Development
11.13 Promega Corporation
11.13.1 Promega Corporation Company Detail
11.13.2 Promega Corporation Business Overview
11.13.3 Promega Corporation Digital PCR and Real-time PCR(qPCR) Introduction
11.13.4 Promega Corporation Revenue in Digital PCR and Real-time PCR(qPCR) Business (2019-2024)
11.13.5 Promega Corporation Recent Development
11.14 Meridian Bioscience
11.14.1 Meridian Bioscience Company Detail
11.14.2 Meridian Bioscience Business Overview
11.14.3 Meridian Bioscience Digital PCR and Real-time PCR(qPCR) Introduction
11.14.4 Meridian Bioscience Revenue in Digital PCR and Real-time PCR(qPCR) Business (2019-2024)
11.14.5 Meridian Bioscience Recent Development
11.15 Analytik Jena AG
11.15.1 Analytik Jena AG Company Detail
11.15.2 Analytik Jena AG Business Overview
11.15.3 Analytik Jena AG Digital PCR and Real-time PCR(qPCR) Introduction
11.15.4 Analytik Jena AG Revenue in Digital PCR and Real-time PCR(qPCR) Business (2019-2024)
11.15.5 Analytik Jena AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
